University Health Network Expands Relationship with Perimeter Medical Imaging
Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced an expanded relationship with University Health Network (UHN), the largest hospital-based research program in Canada, which includes closer research ties and a unique risk-sharing partnership.
Perimeter has worked closely with the Princess Margaret Cancer Centre, a UHN hospital and recognized global leader in cancer research, to test the clinical capabilities of Perimeter’s ‘OTIS’ tumour margin assessment solution. Promising clinical results from the first trial have led to this expansion of the relationship which includes both additional clinical activities and a risk-sharing activity.
“Having better tumour margin assessment tools available to clinicians, especially for breast cancer cases, has the potential of significantly improving outcomes. UHN is committed to finding solutions in real clinical situations. The promising progress in the technology and clinical results have resulted in expanding our relationship with Perimeter”, said Mark Taylor, Director of Commercialization of UHN’s medical technology group, the Techna Institute. “UHN’s Technology Development and Commercialization group is constantly innovating on ways to better interact with industry partners and leverage the assets and know-how of the hospital. This ‘risk-sharing’ approach with Perimeter is a perfect example of this commitment to our patients, and to patients around the world.”
“We are thrilled to be increasing our already close relationship with UHN,” said Paul Weber, Perimeter’s President and CEO. “Princess Margaret Cancer Centre is a world leader in cancer research and the confidence that UHN has shown with this investment adds significant credibility to our solution. Through this collaboration we look forward to bringing solutions to the market which will save patients from unnecessary mental and physical trauma currently experienced by all lumpectomy patients and their families!”
About Princess Margaret Cancer Centre
The Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres and is a member of the University Health Network. For more information, go to www.theprincessmargaret.ca
About University Health Network
University Health Network consists of Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, and Toronto Rehabilitation Institute. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto. www.uhn.ca
About Perimeter Medical Imaging Inc.
Perimeter Medical develops, patents, and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTISTM is the only solution that provides clinicians with an ultra high resolution image of the entire surface of the removed tissue specimen, providing accurate information in real time, enabling better decisions and ultimately reducing the need for follow-on 2nd surgeries. Perimeter is a privately owned Canadian company. For more information, visit www.perimetermed.com.
Paul Weber, President and CEO
Perimeter Medical Imaging Inc.
* CAUTION - OTIS is an investigational device limited by Federal (or United States) law to investigational use.
Released September 15, 2014